Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren's syndrome.
Sjögren's syndrome (SS) is a prototypical systemic autoimmune disease, where autoimmune processes lead to the dysfunction of the exocrine glands. The key feature of the disease is autoimmune exocrinopathy, causing reduced tear secretion and subsequent keratoconjunctivitis sicca (KCS). The aim of this study was to investigate the connection between the presence of autoantibodies to lachrymal gland antigens and the reduced tear production in patients with primary SS. Ninety-nine patients, 90 women and 9 men, were investigated in the study. Twenty healthy young women served as controls. Enzyme-linked immunosorbent assay (ELISA) and Western blotting were applied to detect autoantibodies to antigen fractions prepared from the human lachrymal gland membrane and cytosolic fractions. Autoantibodies of the IgG, IgA and IgM isotypes to the lachrymal membrane and cytosolic fractions were detected in about one third (27%) of the patients with primary SS. IgA antobodies to the membrane and cytosolic fractions occurred most frequently in SS patients. A significant difference was found in the presence of IgA antibodies to the membrane lachrymal fraction between patients and controls given in ELISA indices (1.23 +/- 0.3 vs 1 +/- 0.19, p < 0.001). IgG, IgA, and IgM isotypes of autoantibodies directed to the membrane lachrymal fraction of 200-180, 120-116, 80-70, 58, 50, 48.5, 40 and 28.8 kDa were also identified in patients. Membrane IgG antibody levels showed a positive correlation (R = 0.998; p = 0.045) with the clinical loss of secretory function (Schirmer's test values). Positive correlation was found between membrane IgM and anti-SS-A levels (R = 0.962; p = 0.038) and also between cytosolic IgM antibodies and anti-SS-A levels (R = 0.982; p = 0.018). IgG, IgA and IgM types of autoantibodies may play a role in the development of the impaired lachrymal secretion and therefore may be involved in the pathogenesis of KCS.
Szodoray
Peter
P
Division of Clinical Immunology, 3rd Department of Medicine, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary. peter.szodoray@gades.uib.no
Koczok
Katalin
K
Szanto
Antonia
A
Horvath
Ildiko Fanny
IF
Nakken
Britt
B
Molnar
Ildiko
I
Zeher
Margit
M
D000368:Aged; D001323:Autoantibodies / Q000276:immunology*; D016022:Case-Control Studies; D003600:Cytosol / Q000276:immunology; D005260:Female; D006801:Humans; D007638:Keratoconjunctivitis Sicca / Q000276:immunology; D007765:Lacrimal Apparatus / Q000166:cytology / Q000276:immunology*; D008297:Male; D008566:Membranes / Q000276:immunology; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000276:immunology*
D001323:Autoantibodies
Arthritis Rheum. 1998 Dec;41(12):2238-48
9870881
Gastroenterology. 1996 May;110(5):1579-86
8613065
Invest Ophthalmol Vis Sci. 2000 Mar;41(3):826-31
10711700
Ann Rheum Dis. 2002 Jun;61(6):554-8
12006334
J Rheumatol. 2004 Mar;31(3):504-7
14994395
Crit Rev Oral Biol Med. 2001;12(3):244-51
11497375
J Immunol. 2001 Nov 1;167(9):5449-56
11673564
Ann Rheum Dis. 2002 Jun;61(6):482-4
12006316
Clin Immunol Immunopathol. 1987 Nov;45(2):235-43
3117465
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
388439
Arthritis Rheum. 1999 Aug;42(8):1673-81
10446867
J Rheumatol. 1997 Aug;24(8):1552-7
9263150
Scand J Immunol. 2002 Nov;56(5):456-69
12410795
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):151-6
9430556
Scand J Rheumatol. 2000;29(6):341-8
11132201
Clin Immunol Immunopathol. 1993 Jan;66(1):26-32
8440071
Arthritis Rheum. 1999 Apr;42(4):697-702
10211883
Anal Biochem. 1976 May 7;72:248-54
942051
Science. 1997 Apr 25;276(5312):604-7
9110981
J Rheumatol. 2005 Jan;32(1):197; author reply 197-8
15630756
J Endocrinol Invest. 1995 Jun;18(6):408-14
7594233
J Exp Med. 1994 Apr 1;179(4):1317-30
7511686
Clin Exp Immunol. 1996 Jun;104(3):454-9
9099930
Am J Ophthalmol. 1994 Jan 15;117(1):120-1
7904795